Page last updated: 2024-08-21

methylazoxymethanol acetate and Parkinson Disease, Secondary

methylazoxymethanol acetate has been researched along with Parkinson Disease, Secondary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chlebowski, AC; Eriksen, JL; Kisby, GE; Spencer, PS	1

Other Studies

1 other study(ies) available for methylazoxymethanol acetate and Parkinson Disease, Secondary

Article	Year
Cycad Genotoxin Methylazoxymethanol Disrupts the Brain Ubiquitin-Proteasome Pathway, Tau and α-Synuclein, as Reported in ALS-PDC. Journal of neuropathology and experimental neurology, 2021, 02-22, Volume: 80, Issue:3 Topics: alpha-Synuclein; Amyotrophic Lateral Sclerosis; Animals; Brain; Cycas; Humans; Methylazoxymethanol Acetate; Mice; Mutagens; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Signal Transduction; Ubiquitin	2021

Article

Year

Cycad Genotoxin Methylazoxymethanol Disrupts the Brain Ubiquitin-Proteasome Pathway, Tau and α-Synuclein, as Reported in ALS-PDC.

Journal of neuropathology and experimental neurology, 2021, 02-22, Volume: 80, Issue:3

Topics: alpha-Synuclein; Amyotrophic Lateral Sclerosis; Animals; Brain; Cycas; Humans; Methylazoxymethanol Acetate; Mice; Mutagens; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Signal Transduction; Ubiquitin

2021